日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Discovery of Niclosamide Analogs with Potent Mitochondrial Uncoupling Activity and Reduced Mitochondrial Inhibition-Associated Toxicity

发现具有强效线粒体解偶联活性和降低线粒体抑制相关毒性的尼克酰胺类似物

Jiang, Haowen; Macorano, Alessio; Xing, Enming; Jedoui, Mohamed; Mohammed, Shabber; Lee, Vanessa; Cheng, Jeffrey; McDonough, Lain; Cheng, Xiaolin; Ye, Jiangbin; Li, Pui Kai

Development of Selective and Soluble Mitochondrial Complex 1 Inhibitors Derived from Papaverine for Radiosensitization of Cancer

开发源自罂粟碱的选择性可溶性线粒体复合物I抑制剂用于癌症放射增敏

Haines, Ben J; Kreamer, McKenzie; Benej, Martin; Mohammed, Shabber; Bridge, Haylee; Bayrali-Ulker, Esin; Fergatova, Adel; Williams, Terence M; Li, Zihai; Papandreou, Ioanna; Denko, Nicholas C; Mitton-Fry, Mark J

Valine-Niclosamide for Treatment of Androgen Receptor Splice Variant-Positive Hepatocellular Carcinoma.

缬氨酸-尼克酰胺用于治疗雄激素受体剪接变异体阳性肝细胞癌

Hoelzen Emma J, Radomska Hanna S, Kulp Samuel K, Adeluola Adeoluwa A, Granchie Lauren A, Cheng Jeffrey, Dauki Anees M, Campbell Moray J, Mohammed Shabber, Xing Enming, Hai Min, Fukuda Mayu, Cheng Xiaolin, Phelps Mitch A, Li Pui-Kai, Coss Christopher C

Netupitant Exhibits Potent Activity on Mycobacterium tuberculosis Persisters

奈妥匹坦对结核分枝杆菌持续菌表现出强效活性

Eldesouky, Hassan E; Jones, Richard M; Mohammed, Shabber; Xing, Enming; Li, Pui-Kai; Sherman, David R

LX1 Dual Targets AR Variants and AKR1C3 in Advanced Prostate Cancer Therapy.

LX1 双靶点 AR 变异体和 AKR1C3 在晚期前列腺癌治疗中的应用

Ning Shu, Armstrong Cameron M, Xing Enming, Leslie Amy R, Gao Richard Y, Sharifi Masuda, Schaaf Zachary A, Lou Wei, Han Xiangrui, Xu Desiree H, Yang Rui, Cheng Jeffrey, Mohammed Shabber, Mitsiades Nicholas, Liu Chengfei, Lombard Alan P, Wu Chun-Yi, Cheng Xiaolin, Li Pui-Kai, Gao Allen C

Combinatorial targeting of glutamine metabolism and lysosomal-based lipid metabolism effectively suppresses glioblastoma

谷氨酰胺代谢和溶酶体脂质代谢的组合靶向有效抑制胶质母细胞瘤

Yaogang Zhong, Feng Geng, Logan Mazik, Xinmin Yin, Aline Paixao Becker, Shabber Mohammed, Huali Su, Enming Xing, Yongjun Kou, Cheng-Yao Chiang, Yunzhou Fan, Yongchen Guo, Qiang Wang, Pui-Kai Li, Xiaokui Mo, Etienne Lefai, Liqing He, Xiaolin Cheng, Xiang Zhang, Arnab Chakravarti, Deliang Guo

AFM signal model for dysarthric speech classification using speech biomarkers

基于语音生物标志物的构音障碍语音分类的AFM信号模型

Shabber, Shaik Mulla; Sumesh, Eratt Parameswaran

Cerebral Glucose Metabolism and Potential Effects on Endoplasmic Reticulum Stress in Stroke

脑葡萄糖代谢及其对中风后内质网应激的潜在影响

Guo, Sichao; Wehbe, Alexandra; Syed, Shabber; Wills, Melissa; Guan, Longfei; Lv, Shuyu; Li, Fengwu; Geng, Xiaokun; Ding, Yuchuan

Second-Generation Prostaglandin Receptor EP2 Antagonist, TG8-260, with High Potency, Selectivity, Oral Bioavailability, and Anti-Inflammatory Properties

第二代前列腺素受体 EP2 拮抗剂 TG8-260,具有高效力、选择性、口服生物利用度和抗炎特性

Radhika Amaradhi, Shabber Mohammed, Avijit Banik, Ronald Franklin, Raymond Dingledine, Thota Ganesh

Activation of AcvR1-Mediated Signaling Results in Semilunar Valve Defects

AcvR1 介导的信号激活导致半月瓣缺陷

Shabber Syed, Sudha Rajderkar, Jeffrey M Mann, Travis Hawkins, Bingrou Wu, Bin Zhou, Yukiko Sugi, Yuji Mishina, Vesa Kaartinen